Seroprevalence of SARS-CoV-2 among blood donors: A practical serosurveillance tool for COVID-19.
作者信息
Bansal N, Raturi M, Bansal Y
机构信息
Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India.
Department of Immunohematology and Blood Transfusion, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jolly Grant, Dehradun, Uttarakhand, India.
出版信息
Transfus Clin Biol. 2022 May;29(2):182-183. doi: 10.1016/j.tracli.2021.11.005. Epub 2021 Dec 15.
Abstract
摘要
相似文献
1
Seroprevalence of SARS-CoV-2 among blood donors: A practical serosurveillance tool for COVID-19.
Transfus Clin Biol. 2022 May;29(2):182-183. doi: 10.1016/j.tracli.2021.11.005. Epub 2021 Dec 15.
2
Serosurveillance of SARS-CoV-2 in Welsh Blood Donors: Establishment of the surveillance system and results up to November 2022.
Euro Surveill. 2023 May;28(19). doi: 10.2807/1560-7917.ES.2023.28.19.2200473.
3
Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022.
Emerg Infect Dis. 2023 Sep;29(9):1868-1871. doi: 10.3201/eid2909.230365. Epub 2023 Jul 28.
4
Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.
JAMA. 2021 Oct 12;326(14):1436-1438. doi: 10.1001/jama.2021.15265.
5
Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors.
Lancet Glob Health. 2021 Oct;9(10):e1363-e1364. doi: 10.1016/S2214-109X(21)00361-2.
6
Increased SARS-CoV-2 seroprevalence in healthy blood donors after the second pandemic wave in South-Eastern Italy: evidence for asymptomatic young donors as potential virus spreaders.
Infect Dis (Lond). 2022 Apr;54(4):241-246. doi: 10.1080/23744235.2021.2003856. Epub 2021 Nov 16.
7
High SARS-CoV-2 seroprevalence in blood donors from Romania after the third COVID-19 pandemic wave.
Infect Dis (Lond). 2022 Jul;54(7):534-537. doi: 10.1080/23744235.2022.2036811. Epub 2022 Feb 11.
8
SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020.
J Formos Med Assoc. 2022 Aug;121(8):1615-1616. doi: 10.1016/j.jfma.2022.01.004. Epub 2022 Jan 10.
9
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
JAMA. 2021 Oct 12;326(14):1400-1409. doi: 10.1001/jama.2021.15161.
10
Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
Can J Public Health. 2022 Jun;113(3):385-393. doi: 10.17269/s41997-022-00622-y. Epub 2022 Apr 5.
本文引用的文献
1
SARS COV-2- IgG antibodies in blood donors in pandemic - A game changer for policy makers.
Transfus Clin Biol. 2022 Feb;29(1):11-15. doi: 10.1016/j.tracli.2021.10.004. Epub 2021 Oct 13.
2
Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership.
BMC Infect Dis. 2021 Aug 30;21(1):889. doi: 10.1186/s12879-021-06517-6.
3
COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors.
Transfus Clin Biol. 2021 Aug;28(3):308-309. doi: 10.1016/j.tracli.2021.05.002. Epub 2021 May 7.
4
COVID-19: Is a paradigm change to be expected in health care and transfusion medicine?
Transfus Clin Biol. 2020 Apr;27(2):59-60. doi: 10.1016/j.tracli.2020.03.005. Epub 2020 Mar 31.
5
Screening tests: a review with examples.
Inhal Toxicol. 2014 Nov;26(13):811-28. doi: 10.3109/08958378.2014.955932. Epub 2014 Sep 29.
Zotero 插件